Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

The University of British Columbia

$61,539.00

Pharmacological characterization of phyto-cannabinoids and endocannabinoid system

FY 2024-25

Summary
Endocannabinoids (eCBs) are omnipresent in biological systems and function as neurotransmitters and neuromodulators. Like eCBs, phytocannabinoids (pCBs) have been shown to control motor activity, cognition, sensory perception, as well as several autocrine and endocrine functions. Whether the receptors (cannabinoid and non-cannabinoid) that mediate such effect interact and constitute a novel functional complex is unknown. Therefore, we hypothesize that cannabinoid receptors (CBRs), upon activation with cannabinoids, might form homo-and heterodimers and create a pharmacologically distinct functional entity. Understanding the role of endocannabinoid system (ECS) components, including CBRs, in normal physiology will allow for a better understanding of cannabinoids mediated pharmacobiology. Therefore, we propose to- 1) determine the role of cannabinoids on CBRs interaction and heterodimerization 2) characterize the molecular determinants that regulate CBRs function. 3) characterize the role of cannabinoids in neuritogenesis and changes in proteome/metabolome Using morphological (immunohistochemistry), biochemical (Western blot and Co-IP), biophysical (Pb-FRET analysis), and molecular (RT-PCR) approaches, we will characterize CBR subtypes (and other ECS components) expression and functions in SH-SY5Y cells, neuronal culture and rat brain. Once the role of cannabinoids on CBRs dimerization is identified, we propose to determine the role of effector proteins such as GRKs and membrane entities such as lipid rafts on cross-talk and functional properties. In addition, we propose to study the role of CBRs on neuritogenesis and cannabinoid-mediated changes in intracellular proteome/metabolome to fulfil a wide array of biological functions.
Program
Alliance Grants
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
571272-2021
Name nom
Kumar, Ujendra U
Department département
Pharmaceutical Sciences, Faculty of
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
61539
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5407
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Receptors
Research subject fr
Récepteurs
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Pharmacological characterization of phyto-cannabinoids and endocannabinoid system
Keywords
apoptosis and proliferation; cannabinoid receptors; endocannabinoid system; metabolomics; pb-fret; pharmacology; phyto-cannabinoids; protein-protein interaction; proteomics; signaling
Application summary
Endocannabinoids (eCBs) are omnipresent in biological systems and function as neurotransmitters and neuromodulators. Like eCBs, phytocannabinoids (pCBs) have been shown to control motor activity, cognition, sensory perception, as well as several autocrine and endocrine functions. Whether the receptors (cannabinoid and non-cannabinoid) that mediate such effect interact and constitute a novel functional complex is unknown. Therefore, we hypothesize that cannabinoid receptors (CBRs), upon activation with cannabinoids, might form homo-and heterodimers and create a pharmacologically distinct functional entity. Understanding the role of endocannabinoid system (ECS) components, including CBRs, in normal physiology will allow for a better understanding of cannabinoids mediated pharmacobiology. Therefore, we propose to- 1) determine the role of cannabinoids on CBRs interaction and heterodimerization 2) characterize the molecular determinants that regulate CBRs function. 3) characterize the role of cannabinoids in neuritogenesis and changes in proteome/metabolome Using morphological (immunohistochemistry), biochemical (Western blot and Co-IP), biophysical (Pb-FRET analysis), and molecular (RT-PCR) approaches, we will characterize CBR subtypes (and other ECS components) expression and functions in SH-SY5Y cells, neuronal culture and rat brain. Once the role of cannabinoids on CBRs dimerization is identified, we propose to determine the role of effector proteins such as GRKs and membrane entities such as lipid rafts on cross-talk and functional properties. In addition, we propose to study the role of CBRs on neuritogenesis and cannabinoid-mediated changes in intracellular proteome/metabolome to fulfil a wide array of biological functions.
The University of British Columbia - $61,539 Grant (2… | Canada Spends